Related Experiment Video
Updated: Jun 29, 2026
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Gateways to clinical trials. July-August 2008
Methods and Findings in Experimental and Clinical Pharmacology
|October 14, 2008
Summary
This study provides a comprehensive list of novel therapeutic agents, including small molecules, biologics, and vaccines, for various diseases. It highlights the diverse landscape of drug development and potential new treatments.
Area of Science:
- Pharmaceutical Sciences
- Medicinal Chemistry
- Biotechnology
Context:
- The pharmaceutical industry is continuously developing novel therapeutic agents.
- A wide array of drug candidates, including small molecules, biologics, and vaccines, are under investigation.
- These agents target a broad spectrum of diseases, reflecting the complexity of modern medicine.
Purpose:
- To compile a comprehensive catalog of emerging therapeutic agents.
- To provide an overview of the current landscape of drug discovery and development.
- To serve as a reference for researchers and clinicians.
Summary:
- The abstract lists numerous therapeutic agents such as (-)-Epigallocatechin gallate, Abatacept, Adalimumab, Adefovir dipivoxil, and Bortezomib.
- It includes various drug classes like small molecules (e.g., Apixaban, Everolimus), biologics (e.g., Cetuximab, Denosumab), and vaccines (e.g., MVA-BN Measles, RTS,S/SBAS2).
- The list encompasses agents for oncology, infectious diseases, cardiovascular conditions, and autoimmune disorders, among others.
Impact:
- Facilitates a better understanding of the current drug development pipeline.
- Aids in identifying potential therapeutic options for unmet medical needs.
- Supports research and development by providing a consolidated view of investigational drugs.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...